Blood Reviews
Volume 21, Issue 5 , Pages 267-283 , September 2007

G6PD deficiency: the genotype-phenotype association

  • Philip J Mason

      Affiliations

    • Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, Campus Box 8125, 660 South Euclid Avenue, St. Louis, MO 63110
    • Corresponding Author InformationCorresponding author. Tel.: +1 314 362 8814.
    • ,
  • José M Bautista

      Affiliations

    • Department of Biochemistry and Molecular Biology IV, Universidad Complutense de Madrid, Spain
    • ,
  • Florinda Gilsanz

      Affiliations

    • Haematology Service, University Hospital 12 de Octubre, Universidad Complutense de Madrid, Spain

References 

  1. Carson PE, Flanagan CL, Ickes CE, Alving AS. Enzymatic deficiency in primaquine sensitive erythrocytes. Science. 1956;124:484–485
  2. Beutler E. G6PD deficiency. Blood. 1994;84:3613–3636
  3. Luzzatto L, Vulliamy TJ, Mehta A. Glucose 6-phosphate dehydrogenase deficiency. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001;p. 4517–4553
  4. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277–1282
  5. Allison AC. Glucose-6-phosphate dehydrogenase deficiency in red blood cells of East Africans. Nature. 1960;186:531–532
  6. Motulsky AG. Metabolic polymorphisms and the role of infectious diseases in human evolution. Human Biology. 1960;32:28–62
  7. Ruwende C, Khoo SC, Snow RW, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246–249
  8. Tishkoff SA, Varkonyi R, Cahinhinan N, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001;293:455–462
  9. Beutler E, Vulliamy TJ. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 2002;28:93–103
  10. Au SW, Gover S, Lam VM, Adams MJ. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency. Structure. 2000;8:293–303
  11. Au SW, Naylor CE, Gover S, et al. Solution of the structure of tetrameric human glucose 6-phosphate dehydrogenase by molecular replacement. Acta Crystallogr D Biol Crystallogr. 1999;55:826–834
  12. Kotaka M, Gover S, Vandeputte-Rutten L, Au SW, Lam VM, Adams MJ. Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005;61:495–504
  13. Camardella L, Damonte G, Carratore V, Benatti U, Tonetti M, Moneti G. Glucose 6-phosphate dehydrogenase from human erythrocytes: identification of N-acetyl-alanine at the N-terminus of the mature protein. Biochem Biophys Res Commun. 1995;207:331–338
  14. Cohen P, Rosemeyer MA. Subunit interactions of glucose-6-phosphate dehydrogenase from human erythrocytes. Eur J Biochem. 1969;8:8–15
  15. Filosa S, Fico A, Paglialunga F, et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J. 2003;370:935–943
  16. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. Embo J. 1995;14:5209–5215
  17. Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol. 1992;87:29–31
  18. Maisels MJ. Neonatal jaundice. Pediatr Rev. 2006;27:443–454
  19. Weng YH, Chou YH, Lien RI. Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency. Early Hum Dev. 2003;71:129–136
  20. Beutler E, Gelbart T, Miller W. Severe jaundice in a patient with a previously undescribed glucose-6-phosphate dehydrogenase (G6PD) mutation and Gilbert syndrome. Blood Cells Mol Dis. 2002;28:104–107
  21. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology. 2002;123:127–133
  22. Nicolaidou P, Kostaridou S, Mavri A, Galla A, Kitsiou S, Stamoulakatou A. Glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome: a gene interaction underlies severe jaundice without severe hemolysis. Pediatr Hematol Oncol. 2005;22:561–566
  23. Fiorelli G, Martinez di Montemuros F, Cappellini MD. Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants. Baillieres Best Pract Res Clin Haematol. 2000;13:39–55
  24. Bienzle U, Sodeinde O, Effiong CE, Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community. Blood. 1975;46:591–597
  25. Bernstein SC, Bowman JE, Noche LK. Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon. Hum Hered. 1980;30:7–11
  26. Tagarelli A, Piro A, Bastone L, Tagarelli G. Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia. FEBS Lett. 2000;466:139–142
  27. Balgir RS. Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?. Homo. 2006;57:163–176
  28. Steinberg MH, West MS, Gallagher D, Mentzer W. Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia. Blood. 1988;71:748–752
  29. Than AM, Harano T, Harano K, Myint AA, Ogino T, Okadaa S. High incidence of 3-thalassemia, hemoglobin E, and glucose-6-phosphate dehydrogenase deficiency in populations of malaria-endemic southern Shan State, Myanmar. Int J Hematol. 2005;82:119–123
  30. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med. 1995;333:1171–1175
  31. Cappellini MD, Martinez di Montemuros F, Sampietro M, Tavazzi D, Fiorelli G. The interaction between Gilbert’s syndrome and G6PD deficiency influences bilirubin levels. Br J Haematol. 1999;104:928–929
  32. Iolascon A, Faienza MF, Giordani L, et al. Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert’s syndrome. Eur J Haematol. 1999;62:307–310
  33. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997;94:12128–12132
  34. Spolarics Z, Siddiqi M, Siegel JH, et al. Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med. 2001;29:728–736
  35. Wilmanski J, Villanueva E, Deitch EA, Spolarics Z. Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis. Crit Care Med. 2007;35:510–518
  36. Matsui R, Xu S, Maitland KA, et al. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation. 2005;112:257–263
  37. Cocco P, Todde P, Fornera S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood. 1998;91:706–709
  38. Betke K, Brewer GJ, Kirkman AN, et al. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO scientific group. WHO Tech Rep Ser. 1967.
  39. Vives-Corrons JL, Kuhl W, Pujades MA, Beutler E. Molecular genetics of the glucose-6-phosphate dehydrogenase (G6PD) Mediterranean variant and description of a new G6PD mutant, G6PD Andalus1361A. Am J Hum Genet. 1990;47:575–579
  40. Kurdi-Haidar B, Mason PJ, Berrebi A, et al. Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet. 1990;47:1013–1019
  41. Vulliamy TJ, D’Urso M, Battistuzzi G, et al. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A. 1988;85:5171–5175
  42. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci U S A. 1988;85:3951–3954
  43. Vulliamy TJ, Othman A, Town M, et al. Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A. Proc Natl Acad Sci U S A. 1991;88:8568–8571
  44. Beutler E. Glucose-6-phosphate dehydrogenase: new perspectives. Blood. 1989;73:1397–1401
  45. Chiu DT, Zuo L, Chen E, et al. Two commonly occurring nucleotide base substitutions in Chinese G6PD variants. Biochem Biophys Res Commun. 1991;180:988–993
  46. Jiang W, Yu G, Liu P, et al. Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population. Hum Genet. 2006;119:463–478
  47. Chalvam R, Mukherjee MB, Colah RB, Mohanty D, Ghosh K. G6PD Namoru (208 T–>C) is the major polymorphic variant in the tribal populations in southern India. Br J Haematol. 2007;136:512–513
  48. Kaeda JS, Chhotray GP, Ranjit MR, et al. A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala–>Gly), is the major polymorphic variant in tribal populations in India. Am J Hum Genet. 1995;57:1335–1341
  49. Sukumar S, Mukherjee MB, Colah RB, Mohanty D. Molecular basis of G6PD deficiency in India. Blood Cells Mol Dis. 2004;33:141–145
  50. Rovira A, Vulliamy TJ, Pujades A, Luzzatto L, Corrons JL. The glucose-6-phosphate dehydrogenase (G6PD) deficient variant G6PD Union (454 Arg–>Cys) has a worldwide distribution possibly due to recurrent mutation. Hum Mol Genet. 1994;3:833–835
  51. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria. PLoS Med. 2007;4:e66
  52. Cappadoro M, Giribaldi G, O’Brien E, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood. 1998;92:2527–2534
  53. Saunders MA, Hammer MF, Nachman MW. Nucleotide variability at G6PD and the signature of malarial selection in humans. Genetics. 2002;162:1849–1861
  54. Saunders MA, Slatkin M, Garner C, Hammer MF, Nachman MW. The extent of linkage disequilibrium caused by selection on G6PD in humans. Genetics. 2005;171:1219–1229
  55. Mason PJ, Sonati MF, MacDonald D, et al. New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia. Blood. 1995;85:1377–1380
  56. Vulliamy TJ, Kaeda JS, Ait-Chafa D, et al. Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia. Br J Haematol. 1998;101:670–675
  57. Naylor CE, Rowland P, Basak AK, et al. Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme. Blood. 1996;87:2974–2982
  58. Hirono A, Fujii H, Miwa S. Identification of two novel deletion mutations in glucose-6-phosphate dehydrogenase gene causing hemolytic anemia. Blood. 1995;85:1118–1121
  59. Menounos P, Zervas C, Garinis G, et al. Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population. Hum Hered. 2000;50:237–241
  60. Calabro V, Mason PJ, Filosa S, et al. Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet. 1993;52:527–536
  61. Iwai K, Hirono A, Matsuoka H, et al. Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet. 2001;108:445–449
  62. Saad ST, Salles TS, Arruda VR, Sonati MF, Costa FF. G6PD sumare: a novel mutation in the G6PD gene (1292 T–>G) associated with chronic nonspherocytic anemia. Hum Mutat. 1997;10:245–247
  63. Persico MG, Viglietto G, Martini G, et al. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5’ non-coding region. Nucleic Acids Res. 1986;14:2511–2522
  64. Martini G, Toniolo D, Vulliamy T, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. Embo J. 1986;5:1849–1855
  65. Marks PA, Gross RT. Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait. Journal of Clinical Investigation. 1959;38:2253–2262
  66. Filosa S, Calabro V, Vallone D, et al. Molecular basis of chronic non-spherocytic haemolytic anaemia: a new G6PD variant (393 Arg—-His) with abnormal KmG6P and marked in vivo instability. Br J Haematol. 1992;80:111–116
  67. Nicol CJ, Zielenski J, Tsui LC, Wells PG. An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. Faseb J. 2000;14:111–127
  68. Longo L, Vanegas OC, Patel M, et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. Embo J. 2002;21:4229–4239
  69. Luzzatto L, Allan NC. Different properties of glucose 6-phosphate dehydrogenase from human erythrocytes with normal and abnormal enzyme levels. Biochem Biophys Res Commun. 1965;21:547–554
  70. Kirkman HN, Hendrickson EM. Glucose 6-phosphate dehydrogenase from human erythrocytes. II. Subactive states of the enzyme from normal persons. J Biol Chem. 1962;237:2371–2376
  71. Cheng YS, Tang TK, Hwang M. Amino acid conservation and clinical severity of human glucose-6-phosphate dehydrogenase mutations. J Biomed Sci. 1999;6:106–114
  72. Notaro R, Afolayan A, Luzzatto L. Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history. Faseb J. 2000;14:485–494
  73. Roos D, van Zwieten R, Wijnen JT, et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 1999;94:2955–2962
  74. van Bruggen R, Bautista JM, Petropoulou T, et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 2002;100:1026–1030
  75. Camardella L, Caruso C, Rutigliano B, Romano M, Di Prisco G, Descalzi-Cancedda F. Human erythrocyte glucose-6-phosphate dehydrogenase. Identification of a reactive lysyl residue labelled with pyridoxal 5′-phosphate. Eur J Biochem. 1988;171:485–489
  76. Lee WT, Levy HR. Lysine-21 of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase participates in substrate binding through charge-charge interaction. Protein Sci. 1992;1:329–334
  77. Jeffery J, Persson B, Wood I, Bergman T, Jeffery R, Jornvall H. Glucose-6-phosphate dehydrogenase. Structure-function relationships and the Pichia jadinii enzyme structure. Eur J Biochem. 1993;212:41–49
  78. Rowland P, Basak AK, Gover S, Levy HR, Adams MJ. The three-dimensional structure of glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides refined at 2.0 A resolution. Structure. 1994;2:1073–1087
  79. Babalola AO, Beetlestone JG, Luzzatto L. Genetic variants of human erythrocyte glucose-6-phosphate dehydrogenase. Kinetic and thermodynamic parameters of variants A, B, and A- in relation to quaternary structure. J Biol Chem. 1976;251:2993–3002
  80. Wang XT, Lam VM, Engel PC. Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and Nashville. Biochim Biophys Acta. 2006;1762:767–774
  81. Hirono A, Fujii H, Takano T, Chiba Y, Azuno Y, Miwa S. Molecular analysis of eight biochemically unique glucose-6-phosphate dehydrogenase variants found in Japan. Blood. 1997;89:4624–4627
  82. Hamel AR, Cabral IR, Sales TS, Costa FF, Olalla Saad ST. Molecular heterogeneity of G6PD deficiency in an Amazonian population and description of four new variants. Blood Cells Mol Dis. 2002;28:399–406
  83. Ainoon O, Boo NY, Yu YH, Cheong SK, Hamidah HN. G6PD deficiency with hemolytic anemia due to a rare gene deletion–a report of the first case in Malaysia. Hematology. 2006;11:113–118
  84. De Flora A, Morelli A, Giuliano F. Human erythrocyte glucose 6-phosphate dehydrogenase. Content of bound coenzyme. Biochem Biophys Res Commun. 1974;59:406–413
  85. Hirono A, Kuhl W, Gelbart T, Forman L, Fairbanks VF, Beutler E. Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc Natl Acad Sci U S A. 1989;86:10015–10017
  86. Scopes DA, Bautista JM, Naylor CE, Adams MJ, Mason PJ. Amino acid substitutions at the dimer interface of human glucose-6-phosphate dehydrogenase that increase thermostability and reduce the stabilising effect of NADP. Eur J Biochem. 1998;251:382–388
  87. Gomez-Gallego F, Garrido-Pertierra A, Bautista JM. Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-) deficiency. J Biol Chem. 2000;275:9256–9262
  88. Gomez-Gallego F, Garrido-Pertierra A, Mason PJ, Bautista JM. Unproductive folding of the human G6PD-deficient variant A. Faseb J. 1996;10:153–158
  89. Hirono A, Kawate K, Honda A, Fujii H, Miwa S. A single mutation 202G>A in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself. Blood. 2002;99:1498
  90. Town M, Bautista JM, Mason PJ, Luzzatto L. Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype. Hum Mol Genet. 1992;1:171–174
  91. Yoshida A, Baur EW, Moutlsky AG. A Philippino glucose-6-phosphate dehydrogenase variant (G6PD Union) with enzyme deficiency and altered substrate specificity. Blood. 1970;35:506–513
  92. Wang XT, Lam VM, Engel PC. Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus). Hum Mutat. 2005;26:284
  93. Au WY, Lam V, Pang A, et al. Glucose-6-phosphate dehydrogenase deficiency in female octogenarians, nanogenarians, and centenarians. J Gerontol A Biol Sci Med Sci. 2006;61:1086–1089
  94. Au WY, Ma ES, Lam VM, Chan JL, Pang A, Kwong YL. Glucose 6-phosphate dehydrogenase (G6PD) deficiency in elderly Chinese women heterozygous for G6PD variants. Am J Med Genet A. 2004;129:208–211
  95. Filosa S, Giacometti N, Wangwei C, et al. Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency. Am J Hum Genet. 1996;59:887–895
  96. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol. 1979;43:465–467
  97. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. second ed.. New York: Grune and Stratton; 1975;
  98. Tantular IS, Kawamoto F. An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency. Trop Med Int Health. 2003;8:569–574
  99. Lalloo DG, Shingadia D, Pasvol G, et al. UK malaria treatment guidelines. J Infect. 2007;54:111–121
  100. De Vita G, Alcalay M, Sampietro M, Cappelini MD, Fiorelli G, Toniolo D. Two point mutations are responsible for G6PD polymorphism in Sardinia. Am J Hum Genet. 1989;44:233–240
  101. Hirono A, Miwa S, Fujii H, Ishida F, Yamada K, Kubota K. Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand conformation polymorphism analysis. Blood. 1994;83:3363–3368
  102. Xu W, Westwood B, Bartsocas CS, Malcorra-Azpiazu JJ, Indrak K, Beutler E. Glucose-6 phosphate dehydrogenase mutations and haplotypes in various ethnic groups. Blood. 1995;85:257–263
  103. Hirono A, Fujii H, Miwa S. Molecular abnormality of G6PD Konan and G6PD Ube, the most common glucose-6-phosphate dehydrogenase variants in Japan. Hum Genet. 1993;91:507–508
  104. Ninfali P, Baronciani L, Ruzzo A, et al. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district. Hum Genet. 1993;92:139–142
  105. Takizawa T, Yoneyama Y, Miwa S, Yoshida A. A single nucleotide base transition is the basis of the common human glucose-6-phosphate dehydrogenase variant A (+). Genomics. 1987;1:228–231
  106. Hirono A, Fujii H, Hirono K, Kanno H, Miwa S. Molecular abnormality of a Japanese glucose-6-phosphate dehydrogenase variant (G6PD Tokyo) associated with hereditary non-spherocytic hemolytic anemia. Hum Genet. 1992;88:347–348
  107. Vives-Corrons JL, Pujades MA, Petit J, et al. Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP). Molecular study of a new variant (G6PD Clinic) with markedly acidic pH optimum. Hum Genet. 1989;81:161–164
  108. Beutler E, Westwood B, Melemed A, Dal Borgo P, Margolis D. Three new exon 10 glucose-6-phosphate dehydrogenase mutations. Blood Cells Mol Dis. 1995;21:64–72
  109. Hirono A, Fujii H, Shima M, Miwa S. G6PD Nara: a new class 1 glucose-6-phosphate dehydrogenase variant with an eight amino acid deletion. Blood. 1993;82:3250–3252
  110. Weimer TA, Salzano FM, Westwood B, Beutler E. G6PD variants in three South American ethnic groups: population distribution and description of two new mutations. Hum Hered. 1998;48:92–96
  111. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33–3827–38

PII: S0268-960X(07)00032-X

doi: 10.1016/j.blre.2007.05.002

Blood Reviews
Volume 21, Issue 5 , Pages 267-283 , September 2007

Article Tools

* Image Usage & Resolution